Advertisement

Topics

Abzena invests in expansion of biotherapeutics and makes executive appointment

05:37 EST 7 Nov 2018 | Bionity

Dr. Jonathan Goldman, CEO, announced that Abzena has augmented existing 500 L scale biologics equipment with $20M of investment into two new manufacturing suites at 500 L and 2000 L scale in a new GMP facility in San Diego, which will be equipped with Sartorius single use bioreactors. Abzena’s exist...

Original Article: Abzena invests in expansion of biotherapeutics and makes executive appointment

NEXT ARTICLE

More From BioPortfolio on "Abzena invests in expansion of biotherapeutics and makes executive appointment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...